Andrew G Lee, Nancy J Newman. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 3',5'-Cyclic-GMP Phosphodiesterases/antagonists & inhibitorsAdverse Drug Reaction Reporting Systems/statistics & numerical dataCyclic Nucleotide Phosphodiesterases, Type 5Erectile Dysfunction/drug therapyHumansMaleOptic Neuropathy, Ischemic/chemically inducedPhosphodiesterase Inhibitors/adverse effectsPhosphoric Diester HydrolasesPractice Guidelines as TopicUnited StatesUnited States Food and Drug AdministrationVision Disorders/chemically induced
Substances: See more » Phosphodiesterase InhibitorsPhosphoric Diester Hydrolases3',5'-Cyclic-GMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 5PDE5A protein, human
Year: 2005 PMID: 16226524 DOI: 10.1016/j.ajo.2005.07.055
Source DB: PubMed Journal: Am J Ophthalmol ISSN: 0002-9394 Impact factor: 5.258